ADK, adenosine kinase, 132

N. diseases: 102; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.010 Biomarker group BEFREE They may be used to mimic the genetic deficiency of the enzyme, in lymphoproliferative disorders or immunosuppressive therapy (i.e., in graft rejection), to potentiate the effect of antileukemic or antiviral nucleosides, and, together with adenosine kinase, to reduce breakdown of adenosine in inflammation, hypertension, and ischemic injury. 11223861 2001